{{Rsnum
|rsid=5845
|Gene=SEP15
|Chromosome=1
|position=86863156
|Orientation=plus
|GMAF=0.2608
|Gene_s=SEP15
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 5.3 | 39.8 | 54.9
| HCB | 0.0 | 10.3 | 89.7
| JPT | 0.0 | 10.9 | 89.1
| YRI | 41.8 | 49.3 | 8.9
| ASW | 32.1 | 46.4 | 21.4
| CHB | 0.0 | 10.3 | 89.7
| CHD | 0.0 | 4.6 | 95.4
| GIH | 4.0 | 33.0 | 63.0
| LWK | 38.5 | 50.5 | 11.0
| MEX | 5.2 | 36.2 | 58.6
| MKK | 21.2 | 49.4 | 29.5
| TSI | 4.0 | 27.7 | 68.3
| HapMapRevision=28
}}{{PMID Auto
|PMID=21052528
|Title=Polymorphisms in the selenoprotein S and 15-kDa selenoprotein genes are associated with altered susceptibility to colorectal cancer
|OA=1
}}

{{PMID Auto
|PMID=22139612
|Title=Serum selenium and single-nucleotide polymorphisms in genes for selenoproteins: relationship to markers of oxidative stress in men from Auckland, New Zealand.
|OA=1
}}

{{PMID Auto
|PMID=23363810
|Title=Prostate disease risk factors among a New Zealand cohort
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}